DRUG DISCOVERY & DEVELOPMENT
WITH A BETTER ASSESSMENT
OF YOUR COMPOUNDS ON REGULATORY T CELLS
ABOUT US
Immune insighT is a Contract Research Organization (CRO) based In Lille (France) founded in 2016, Spin-off which stems from academic research.
We are specialized in ex-vivo and in-vivo assessment of compounds on the immune system and more specifically regulatory T cells (Tregs).
OUR SCIENCE
Molecular insight
An original Treg Molecular Signature (TregSign kit) which allows, in a single assay, a complete transcriptomic study of Tregs.
KNOW MORE
Cellular insight
A wide range of methods to comprehensively assess the efficacy and safety of your compound of interest on Treg Biology.
KNOW MORE
Animal insight
In vivo assessment of a compound efficacy and safety can be carried out on a human cancer model designed for you (Syngeneic, PDX-Like models…).
KNOW MORE
NEWS
December 2020
Immune insighT participated in the International Biofit conference on 7th – 10th December 2020
November 2020
Immune insighT is a proud sponsor of the PROVENTA INTERNATIONAL :
Online Oncology strategy Meeting (3rd November)
Come meet with us at the Proventa: Online Strategy Meeting.
We will be at the round table discussions surrounding ADCs and ICI in Oncology.
OUR PARTNERS
Previous
Next